Keel Point’s Verona Pharma VRNA Stock Holding History

Keel Point’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,875	Closed	-$200K	–	568
2025 Q3	$200K	Sell	1,875 -313	-14%	-$32.7K	0.01%	508
2025 Q2	$207K	Buy	+2,188	New	+$162K	0.01%	485

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Keel Point's VRNA Position: Q4 2025 in Review

Keel Point sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 1,875 shares — an estimated $200K sold.

Keel Point first reported a position in VRNA in Q2 2025 and held it in 2 quarters. The position peaked at $207K in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Keel Point reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Keel Point sold 1,875 Verona Pharma shares in Q4 2025, an estimated $200K.
Keel Point first reported a position in Verona Pharma in Q2 2025 and held it in 2 quarters.
Keel Point's Verona Pharma position peaked at $207K in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Keel Point's 13F filing for Q4 2025, filed 12 Feb 2026.